Keyphrases
Schizophrenia
100%
Tardive Dyskinesia
100%
Functional Polymorphism
100%
Cytochrome P450 1A2 (CYP1A2)
100%
Gene Association
100%
Smokers
44%
Patients with Schizophrenia
33%
Abnormal Involuntary Movement Scale
33%
Genotype
22%
Genetic Polymorphism
22%
Antipsychotics
22%
Polymorphism
22%
Homozygote
22%
Inducibility
22%
Patient Demographics
11%
Healthy Volunteers
11%
Inducer
11%
Clinical Significance
11%
Genetic Risk
11%
Plasma Concentration
11%
Typical Antipsychotics
11%
General Patients
11%
Heterozygote
11%
Long-term Treatment
11%
First Intron
11%
Person-to-person
11%
Biochemistry, Genetics and Molecular Biology
CYP1A2
100%
Smoking
44%
Involuntary Movement
33%
Genotyping
22%
Genetic Polymorphism
22%
Homozygote
22%
Typical Antipsychotic
22%
Enzyme
11%
Genetic Risk
11%
Blood Level
11%
Normal Human
11%
Intron
11%
Neuroscience
Tardive Dyskinesia
100%
Cytochrome P450 1A2
100%
Dyskinesia
33%
Genetic Polymorphism
22%
Typical Antipsychotic
22%
Antipsychotic
11%
Intron
11%
Blood Plasma
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tardive Dyskinesia
100%
CYP1A2
100%
Dyskinesia
33%
Typical Antipsychotic
22%
Normal Human
11%
Genetic Risk
11%
Side Effect
11%
Antipsychotic
11%